BSX vs MDT — which stock performed better?

Boston Scientific Corporation (BSX) versus Medtronic plc (MDT), Health Care, on 2026-09-08.

Result

Medtronic plc (MDT) performed better on 2026-09-08. BSX moved -4.330%, MDT moved 1.140%.

Why these two companies

A Daily Political roundup of MarketBeat's stock screener published on Friday, September 4, 2026 flagged Boston Scientific and Medtronic together as medical-device names to watch, putting the sector's sharpest growth-versus-value debate back in view. Boston Scientific has been the medtech momentum story on the back of its Farapulse heart-ablation rollout, while Medtronic is the larger, cheaper turnaround play leaning on cost cuts and its renal-denervation launch. Pairing the two lets players weigh a premium-priced grower against a value-priced restructuring story in the same session.

The research

Boston Scientific makes medical devices that doctors use to treat heart conditions and other health problems, including tools that help stop dangerous heart rhythms and reduce stroke risk. Medtronic makes an even wider range of medical equipment used in hospitals around the world, from heart devices to brain and spine tools to surgical robots.

One reason someone might pick Boston Scientific is that its newer heart-treatment products have been selling extremely well and growing much faster than the rest of the industry. One reason someone might pick Medtronic is that it is cheaper relative to its earnings, pays a solid dividend, and is in the middle of a turnaround plan aimed at speeding up its own growth.

Something to keep in mind with Boston Scientific is that its stock price already reflects high expectations, so any disappointment in its newest products could hit it harder than a company with lower expectations. Something to keep in mind with Medtronic is that its turnaround takes time to show results, so it may keep moving more slowly than faster-growing rivals in the meantime.

Both companies sell into the same hospitals and often compete directly for the same procedures, which is part of what makes comparing them on any single trading day an interesting exercise.